The combination of urinary and recombinant HCG improves outcome in patients with decreased oocyte/follicle ratio in previous cycles.
This report describes three cases in which the addition of recombinant HCG to urinary HCG to trigger ovulation in IVF improved oocyte recovery in patients with a history of scant oocyte yield in previous cycles.
Littman
Eva D
ED
Department of OB/GYN, Division of Reproductive Endocrinology and Infertility, Stanford University Medical Center, 300 Pasteur Drive, HH333, Stanford, CA 94305, USA.
Milki
Amin A
AA
D000328:Adult; D006063:Chorionic Gonadotropin / Q000008:administration & dosage* / Q000652:urine*; D005260:Female; D005307:Fertilization in Vitro; D005640:Follicle Stimulating Hormone / Q000008:administration & dosage; D006801:Humans; D008596:Menotropins / Q000008:administration & dosage; D009865:Oocytes; D006080:Ovarian Follicle / Q000166:cytology*; D010062:Ovulation Induction / Q000379:methods*; D011994:Recombinant Proteins / Q000008:administration & dosage; D020554:Sperm Injections, Intracytoplasmic
D006063:Chorionic Gonadotropin; D011994:Recombinant Proteins; D008596:Menotropins; D005640:Follicle Stimulating Hormone